رفتن به محتوای اصلی
x
ردیف عنوان تاریخ ارائه تفسیر آماری توضیحات
1 JC1

American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part1

2 JC2

American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part2

3 JC19

Less is More: Comparing the 2015 and 2009 American Thyroid Association Guidelines for Thyroid Nodules and Cancer

4 JC20

Imaging of the parathyroid glands in primary hyperparathyroidism

5 JC21

Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline

6 JC22

Factitious Graves’ Disease Due to Biotin Immunoassay Interference—A Case and Review of the Literature

7 JC23

Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors

8 JC24

Endocrine role of bone: recent and emerging perspectives beyond osteocalcin

9 JC25

Elevated PTH with normal serum calcium level: a structured approach

10 JC26

Dyslipidemia in Pregnancy

11 JC27

Delaying Radioactive Iodine Ablation for up to One Year Does Not Increase Recurrence for Patients with Differentiated Thyroid Cancer

12 JC28

Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR 45 mLmin)

13 JC29

Certain Clinical Features and Treatments May Be Associated with Increased Mortality in  Thyroid Storm

14 JC30

Antithyroid Drug Use in Pregnancy and Birth Defects: Why Some Studies Find Clear Associations, and Some Studies Report None

15 JC31

American Association of Clinical Endocrinologists, American College of Endocrinology disease state Clinical review. Clinical Relevance of Macroprolactin in the Absence or Presence of true Hyperprolactinemia

16 JC32

American Association of Clinical Endocrinologists and American College of Endocrinology disease state Clinical review: Postoperative Hypoparathyroidism- Definitions and Managment

17 JC18

Limitation of Current Approaches for the Treatment of Acromegaly

18 JC3

Underdiagnoses and Undertreatment of Osteoporosis: The Battle to Be Won

19 JC17

Low-Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A Systematic Review of the Literature

20 JC4

Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline

21 JC5

Thyrotoxicosis associated with the use of amiodarone: the utility of ultrasound in patient management

22 JC6

Thyroid Nodules

23 JC7

Thyroid and Pregnancy in Tehran, Iran: Objectives and Study Protocol

24 JC8

The Management of Primary Aldosteronism Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline

25 JC9

The Emerging role of Adjunctive noninsulin Antihyperglycemic therapy in the Management of type 1 Diabetes

26 JC10

Successful Treatment of Type B Insulin Resistance With Rituximab

27 JC11

Pituitary Tumor Management in Pregnancy

28 JC12

Pituitary apoplexy

29 JC13

Outcome of adrenal sparing surgery in heritable pheochromocytoma

30 JC14

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

31 JC15

Medical Management of Extrathyroidal Manifestation of Graves Disease

32 JC16

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

33 JC53

Tafsir2.jpg

Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD

34 JC52

Tafsir2.jpg

Excess Mortality among Persons with Type 2 diabetes

35 JC50

Tafsir2.jpg

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS)

36 JC49

Tafsir2.jpg

Does Sitagliptin Affect the Rate of Osteoporotic Fractures in Type 2 Diabetes? Population-Based Cohort Study

37 JC48

Tafsir2.jpg

Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW

38 JC54

Tafsir2.jpg

Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency

39 JC55

Tafsir2.jpg

Factors Associated With Cardiovascular Events in Patients With Type 2 Diabetes and Acute Myocardial infarction

40 JC56

Tafsir2.jpg

Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes

41 JC57

Tafsir2.jpg

Hypothyroidism Following Hemithyroidectomy: Incidence, Risk Factors, and Clinical Characteristics

42 JC58

Tafsir2.jpg

Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma

43 JC59

Tafsir2.jpg

Increasing maternal obesity is associated with alterations in both maternal and neonatal thyroid hormone levels

44 JC60

Tafsir2.jpg

Insulin Dose and Cardiovascular Mortality in the ACCORD Trial

45 JC51

Tafsir2.jpg

Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis

46 JC47

Tafsir2.jpg

Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates

47 JC46

Tafsir2.jpg

Defining the Newborn Blood Spot Screening Reference Interval for TSH: Impact of Ethnicity

48 JC34

Acid–Base Problems in Diabetic Ketoacidosis

49 JC35

Tafsir2.jpg

A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients With Type 2 Diabetes

50 JC36

Tafsir2.jpg

A Novel Insulin Resistance Index to Monitor Changes in Insulin Sensitivity and Glucose Tolerance: the ACT NOW Study

51 JC37

Tafsir2.jpg

Abnormal Responsiveness to Dexamethasone-Suppressed CRH Test in Patients With Bilateral Adrenal Incidentalomas

52 JC38

Tafsir2.jpg

ACTH stimulation tests for the diagnosis of adrenal insufficiency: Systematic review and meta-analysis

53 JC39

Tafsir2.jpg

Ambient Light Exposure and Changes in Obesity Parameters: A Longitudinal Study of the HEIJO-KYO Cohort

54 JC40

Tafsir2.jpg

AMH measurement vesus ovarian ultrasound in the diagnostics of polycystic ovary syndrome in different phenotypes

55 JC33

American Association of Clinical Endocrinologists and  American College of Endocrinology 2016 Outpatient Glucose Monitoring Consensus Statement

56 JC45

Tafsir2.jpg

Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes

57 JC44

Tafsir2.jpg

Clomiphene Citrate for Treatment of Acromegaly Not Controlled by Conventional Therapies

58 JC43

Tafsir2.jpg

Circulating Cytokines Predict the Development of Insulin Resistance in a Prospective Finnish Population Cohort

59 JC42

Tafsir2.jpg

Association Between Hyponatremia, Osteoporosis,and Fracture A Systematic Review and Meta-analysis

60 JC41

Tafsir2.jpg

Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With type 1 diabetes

61 JC76

Tafsir2.jpg

Risk Stratification of Neck Lesions Detected Sonographically During the Follow-Up of Differentiated Thyroid Cancer

62 JC77

Tafsir2.jpg

Risk Stratification of Thyroid Incidentalomas Found on PET/CT: The Value of Iodine Content on Noncontrast Computed Tomography

63 JC78

Tafsir2.jpg

Salivary Cortisone Reflects Cortisol Exposure Under Physiological Conditions and After Hydrocortisone

64 JC79

Tafsir2.jpg

Sex-Dimorphic Effects of Prenatal Treatment With Dexamethasone

65 JC75

Tafsir2.jpg

Pre-pregnancy adverse lipid profile and subsequent risk of gestational diabetes

66 JC80

Tafsir2.jpg

Subclinical hypothyroidism and cognitive function in people over 60 years: a systematic review and meta-analysis

67 JC81

Tafsir2.jpg

The Association Between Air Pollution Exposure and Glucose and Lipids Levels

68 JC82

Tafsir2.jpg

The Association Between Sleep Duration, Insulin Sensitivity, and -Cell Function: The EGIR-RISC Study

69 JC83

Tafsir2.jpg

The Relationship Between Parathyroid Hormone and 25-Hydroxyvitamin D During and After Pregnancy

70 JC84

Tafsir2.jpg

Triglyceride Levels and Fracture Risk in Midlife Women: Study of Women’s Health Across the Nation (SWAN)

71 JC85

Tafsir2.jpg

Use of Antibiotics and Risk of Type 2 Diabetes: A Population-Based Case-Control Study

72 JC86

Tafsir2.jpg

Use of Estrogen-Containing Contraception Is Associated With Increased Concentrations of 25-Hydroxy Vitamin D

73 JC74

Tafsir2.jpg

Preconception Low Dose Aspirin and Time to Pregnancy: Findings From the Effects of Aspirin in Gestation and Reproduction Randomized Trial

74 JC73

Tafsir2.jpg

Preablative Stimulated Thyroglobulin Correlates to New Therapy Response System in Differentiated Thyroid Cancer

75 JC67

Tafsir2.jpg

Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987–2012

76 JC61

Tafsir2.jpg

Insulin Enhances Endothelial Function Throughout the Arterial Tree in Healthy But Not Metabolic syndrome subjects

77 JC62

Tafsir2.jpg

Intake of Lactobacillus reuteri Improves Incretin and Insulin Secretion in Glucose-Tolerant Humans: A Proof of Concept

78 JC63

Tafsir2.jpg

Intensive Diabetes Therapy and Ocular Surgery in Type 1 Diabetes

79 JC64

Tafsir2.jpg

Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up

80 JC65

Tafsir2.jpg

Is insulin-like growth factor-I a good marker for treatment adherence in growth hormone deficiency in adulthood

81 JC66

Tafsir2.jpg

Long-Term Outcome in Levothyroxine Treated Patients With Subclinical Hypothyroidism and concomitant heart disease

82 JC68

Tafsir2.jpg

Maternal Thyroid Disease and Preterm Birth: Systematic Review and Meta-Analysis

83 JC69

Tafsir2.jpg

Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin

84 JC70

Tafsir2.jpg

Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial

85 JC71

Tafsir2.jpg

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

86 JC72

Tafsir2.jpg

Plasma DPP4 Activities Are Associated With Osteoporosis in Postmenopausal Women With Normal Glucose Tolerance

87 JC111

1396/02/16

Tafsir2.jpg

Long-Term Effect of Adrenalectomy on Cardiovascular Remodeling in Patients With Pheochromocytoma

88 JC110

1396/02/09

Tafsir2.jpg

Thiazide Treatment in Primary Hyperparathyroidism—A New Indication for an Old Medication

89 JC109

1396/02/09

Tafsir2.jpg

Long-Term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma

90 JC108

1396/02/02

Tafsir2.jpg

Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea

91 JC107

1396/01/26

Tafsir2.jpg

Thyroglobulin as a Functional Biomarker of Iodine Status in a Cohort Study of Pregnant Women in the United Kingdom

92 JC106

1396/01/19

Tafsir2.jpg

Low-Dose Aspirin and Sporadic Anovulation

93 JC105

1396/01/19

Tafsir2.jpg

Characteristics of Men Who Report Persistent Sexua lSymptoms After Finasteride Use for Hair Loss

94 JC112

1396/02/30

Tafsir2.jpg

Bone Turnover Is Suppressed in Insulin Resistance, Independent of Adiposity

95 JC113

1396/03/06

Tafsir2.jpg

Clinical Features of Early and Late Postoperative hypothyroidism after lobectomy

96 JC114

1396/03/06

Tafsir2.jpg

Thyroid Hormone Therapy for Older Adults with subclinical hypothyroidism

97 JC115

1396/03/13

Tafsir2.jpg

Characteristics of Pediatric vs Adult pheochromocytomas and paragangliomas

98 JC116

1396/03/13

Tafsir2.jpg

Effects of Metreleptin in Pediatric Patients eith lipodystrophy

99 JC117

1396/03/20

Tafsir2.jpg

Duodenal Mucosa of Patients With Type 1 DiabetesShows Distinctive Inflammatory Profile and Microbiota

100 JC118

1396/03/20

Tafsir2.jpg

Skeletal Complications and Mortality in Thyroid Cancer

101 JC119

1396/03/27

Tafsir2.jpg

Effects of Cholecalciferol vs Calcifediol on Total andFree 25-Hydroxyvitamin D and Parathyroid Hormone

102 JC120

1396/03/27

Tafsir2.jpg

Metabolically Healthy Obesity and Ischemic Heart disease

103 JC104

1395/12/14

Tafsir2.jpg

No Increase in Fractures After Stopping Hormone Therapy: Results From the Women’s Health Initiative

104 JC103

1395/12/14

Tafsir2.jpg

Effects of Oxandrolone on Cardiometabolic Health in Boys With Klinefelter Syndrome: A Randomized Controlled Trial

105 JC87

Tafsir2.jpg

Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation

106 JC88

Tafsir2.jpg

Abnormal Responsiveness to Dexamethasone-Suppressed CRH Test in Patients With Bilateral Adrenal Incidentalomas

107 JC89

Tafsir2.jpg

Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data

108 JC90

Tafsir2.jpg

Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men

109 JC91

Tafsir2.jpg

Is a second recombinant human thyrotropin stimulation test useful? The value of postsurgical undetectable stimulated thyroglobulin level at the time of remnant ablation on clinical outcome

110 JC92

Tafsir2.jpg

Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987–2012

111 JC93

Tafsir2.jpg

Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature

112 JC94

Tafsir2.jpg

Serum fibroblast growth factor 21 is a superior biomarker to other adipokines in predicting incident diabetes

113 JC95

1395/11/09

Tafsir2.jpg

Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism

114 JC102

1395/12/07

Tafsir2.jpg

Vertebral Fractures and Bone Mineral Density in Patients With Idiopathic Hypoparathyroidism on Long-Term Follow-Up

115 JC100

1395/11/30

Tafsir2.jpg

Urinary Citrate, an Index of Acid-Base Status, Predicts Bone Strength in Youths and Fracture Risk in adult females

116 Jc101

1395/12/07

Tafsir2.jpg

The Desmopressin Test Predicts Better Than Basal Cortisol the Long-Term Surgical Outcome of Cushing’s Disease

117 JC99

1395/11/23

Tafsir2.jpg

The Effect of TSH Suppression on Vertebral Trabecular Bone Scores in Patients With Differentiated thyroid carcinoma

118 JC98

1395/11/23

Tafsir2.jpg

Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma

119 JC97

1395/11/16

Tafsir2.jpg

Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma Is Associated With Aggressive Histopathological Features and a Poor Outcome: Results of a Large Multicentric Study

120 JC96

1395/11/09

Tafsir2.jpg

Drug-induced HPA axis alterations during acute critical illness: a multivariable association study

121 JC132

1396/07/22

Obesity and Metabolic Unhealthiness Have Different Effects on Colorectal Neoplasms

122 JC131

1396/07/15

Distinguishing Parathyroid and Thyroid Lesions on Ultrasound-Guided Fine-Needle Aspiration: A Correlation of Clinical Data, Ancillary Studies, and Molecular Analysis

123 JC130

1396/07/15

 

TERT, BRAF ,and NRAS in Primary Thyroid Cancer and Metastatic Disease

 

124 JC129

1396/07/01

Subclinical Hypothyroidism

125 JC128

1396/07/01

β Cells Persist in T1D Pancreata Without Evidence of Ongoing β-Cell Turnoveror Neogenesis

126 JC127

1396/04/17

Role of First-Trimester HbA1c as a Predictor of Adverse Obstetric Outcomes in a Multiethnic Cohort

127 JC126

1396/04/17

Metabolically Healthy Obesity and Ischemic Heart disease

128 JC125

1396/04/10

In Vitro Head-to-Head Comparison Between Octreotideand Pasireotide in GH-Secreting Pituitary Adenomas

129 JC124

1396/04/10

Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy

130 JC123

1396/04/03

Tafsir2.jpg

Effect of Liraglutide Therapy on Liver Fat Content in Patients With InadequatelyPatients With Inadequately Controlled Type 2 Diabetes

131 JC122

1396/04/03

Tafsir2.jpg

Chronic Intranasal Insulin Does Not Affect Hepatic Lipids but Lowers Circulating BCAAs in Healthy Male Subjects

132 JC121

1396/03/27

Tafsir2.jpg

Role of First-Trimester HbA1c as a Predictor of Adverse Obstetric Outcomes in a Multiethnic Cohort

133 JC133

1396/07/22

Management of Inpatient Hyperglycemia and Diabetes in Older Adults

134 JC134

1396/07/29

Hemoglobin Glycation Index Is Associated With Cardiovascular Diseases in People With Impaired Glucose Metabolism

135 JC150

1396/09/25

Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

136 JC149

1396/09/25

Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial

137 JC148

1396/09/18

Magnesium Intake, Quality of Carbohydrates, and Risk of Type 2 Diabetes: Results From Three U.S. Cohorts

138 JC147

1396/09/18

Associations of Fats and Carbohydrate Intake with Cardiovascular Disease and Mortality in 18 Countries from Five Continents (PURE): A Prospective Cohort Study

139 JC146

1396/09/11

Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study

140 JC145

1396/09/11

Prognostic Value of Preoperative Anti- Thyroglobulin Antibody in Differentiated Thyroid Cancer

141 JC145

1396/09/04

The 2017 Bethesda System for Reporting Thyroid Cytopathology

142 JC144

1396/09/04

Diabetes, Prediabetes, and BrainVolumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)

143 JC143

1396/08/27

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

144 JC142

1396/08/27

Changes in Visceral Adiposity, Subcutaneous Adiposity, and Sex Hormones in the Diabetes Prevention Program

145 JC135

1396/07/29

Thymic Hyperplasia Associated with Graves’ Disease Pathophysiology and Proposed Management Algorithm

146 JC136

1396/08/06

Long-Term Antithyroid Drug Treatment

147 JC137

1396/08/06

Pituitary Tumor Suppression by Combination of Cabergoline and Chloroquine

148 JC138

1396/08/13

The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients

149 JC139

1396/08/13

The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer

150 JC140

1396/08/20

Parity and Risk of Thyroid Autoimmunity Based on the NHANES (2001–2002, 2007–2008, 2009–2010,and 2011–2012)

151 JC141

1396/08/20

Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification

152 JC166

1396/11/21

PTH(1–34) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life

153 JC165

1396/11/21

Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment

154 JC167

1396/11/28

Males with prolactinoma are at increased risk of incident cardiovascular disease

155 JC168

1396/11/28

Serum 25- hydroxyvitamin D as a predictor of mortality and cardiovascular events: A 20- year study of a community- based cohort

156 JC169

1396/12/05

Recent Pregnancy Is Not Associated with High-Risk Pathological Features of Well-Differentiated Thyroid Cancer

157 JC170

1396/12/05

Clinical Fractures Among Older Men With Diabetes Are Mediated by Diabetic Complications

158 JC171

1396/12/12

Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia

159 JC172

1396/12/12

The Value of Perioperative Levels of ACTH, DHEA, and DHEA-S and Tumor Size in Predicting Recurrence of Cushing Disease

160 JC173

1396/12/19

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

161 JC174

1396/12/19

Low Incidence of End-Stage Renal Disease in Childhood-Onset Type 1 Diabetes Followed  for Up to 42 Years

162 JC175

1397/01/18

Lower Trabecular Bone Score in Patients With Primary Aldosteronism: Human Skeletal Deterioration by Aldosterone Excess

163 JC164

1396/11/14

Prevention of total thyroidectomy in noninvasive follicular thyroid neoplasm with papillary- like nuclear features (NIFTP) based on combined interpretation of ultrasonographic and cytopathologic results

164 JC163

1396/11/14

Prolactinoma management predictors of remission and recurrence after dopamine agonists withdrawal

165 JC162

1396/11/07

Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer

166 JC151

1396/10/02

Magnesium Intake, Quality of Carbohydrates, and Risk of Type 2 Diabetes: Results From Three U.S. Cohorts

167 JC152

1396/10/02

Maternal Thyroid Antibodies Associates With Cardiometabolic Risk Factors in Children at the Age of 16

168 JC153

1396/10/09

Differential Growth Rates of Benign vs. Malignant Thyroid Nodules

169 JC154

1396/10/09

Health Effects of Overweight and Obesity in 195 Countries over 25 Years

170 JC155

1396/10/16

Air Pollution and Mortality in the Medicare Population

171 JC156

1396/10/16

DPP4 Inhibitor Sitagliptin as a Potential Treatment Option in Metformin Intolerant Obese Women with Polycystic Ovary Syndrome: a Pilot Randomized Study

172 JC157

1396/10/23

Low Plasma Adiponectin Concentrations Predict Increases in Visceral Adiposity and Insulin Resistance

173 JC158

1396/10/23

The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults

174 JC159

1396/10/30

Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016)

175 JC160

1396/10/30

Sex Difference in the Clinical Presentation of Primary Hyperparathyroidism: Influence of Menopausal Status

176 JC161

1396/11/07

Bone Turnover Markers After Sleep Restriction and Circadian Disruption: A Mechanism for Sleep-Related Bone Loss in Humans

177 JC202

1397/08/12

Limitations of the 2015 ATA Guidelines for Prediction of Thyroid Cancer: A Review of 1947 Consecutive Aspirations

178 JC201

1397/08/05

Statin Use Is Associated With Decreased Osteoporosis and Fracture Risks in Stroke Patients

179 JC200

1397/08/05

Association of Vitamin D Deficiency With Peripheral Arterial Disease

180 JC198

1397/07/28

Association Between Diabetic Retinopathy and Parkinson Disease: The Korean National Health Insurance Service Database

181 JC197

1397/07/21

Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNAC

182 JC196

1397/07/21

Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly

183 JC195

1397/07/14

2018European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction

184 JC203

1397/08/12

Benign Thyroid Diseases and Risk of Thyroid Cancer: A Nationwide Cohort Study

185 JC204

1397/08/19

Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial

186 JC205

1397/08/19

Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies

187 JC206

1397/08/26

Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis

188 JC207

1397/08/26

Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study

189 JC208

1397/09/03

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

190 JC209

1397/09/03

A Comparison of the 2017 American College of Cardiology / American Heart Association Blood Pressure Guideline and the 2017 American Diabetes Association Diabetes and Hypertension Position Statement for U.S. Adults With Diabetes

191 JC210

1397/09/10

Fracture Prevention with Zoledronate in Older Women with Osteopenia

192 JC211

1397/09/10

Iron Deficiency May Predict Greater Risk for Hypothyroxinemia: A Retrospective Cohort Study of Pregnant Women in China

193 JC199

1397/07/28

One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes

194 JC194

1397/07/14

Effectiveness of Prenatal Vitamin D Deficiency Screening and Treatment Program: A Stratified Randomized Field Trial

195 JC193

1397/07/07

Percutaneous Ethanol Injection for Benign Cystic and Mixed Thyroid Nodules

196 JC183

1397/02/22

Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes A Randomized Clinical Trial

197 JC182

1397/02/15

Second Radioiodine Treatment: Limited Benefit for Differentiated Thyroid Cancer With Locoregional Persistent Disease

198 JC181

1397/02/15

High Serum Cholesterol Is a Novel Risk Factor for Graves’ Orbitopathy: Results of a Cross-Sectional Study

199 JC180

1397/02/08

Maternal Thyroid Function in Early Pregnancy and Neuropsychological Performance of the Child at 5 Years of Age

200 JC179

1397/02/08

Reducing Cholesterol and Fat Intake Improves Glucose Tolerance by Enhancing b Cell Function in Nondiabetic Subjects

201 JC178

1397/02/01

Decreasing Use of Radioactive Iodine for Low-Risk Thyroid Cancer in California, 1999 to 2015

202 JC177

1397/02/01

Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism, Negative for Thyroid Peroxidase Antibodies

203 JC176

1397/01/18

Natural History of Contralateral Nodules After Lobectomy in Patients With Papillary Thyroid Carcinoma

204 JC184

1397/02/22

2018European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction

205 JC185

1397/02/29

Bilateral Adrenalectomy in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis

206 JC192

1397/07/07

Cancer Incidence in Patients With Acromegaly: A Cohort Study and Meta-Analysis of the Literature

207 JC191

1397/03/19

Lactation Duration and Progression to Diabetes in Women Across the Childbearing Years The 30-Year CARDIA Study

208 JC190

1397/03/19

Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: a meta-analysis of randomised controlled trials

209 JC189

1397/03/12

Use of Hormone Replacement in Females with Endocrine Disorders

210 JC188

1397/03/12

Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations

211 JC187

1397/03/05

Meat Cooking Methods and Risk of Type 2 Diabetes: Results From Three Prospective Cohort Studies

212 JC186

1397/02/29

Update on Diabetic Nephropathy: Core Curriculum 2018

213 JC229

1397/11/27

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

214 JC230

1397/11/27

Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and - or a sulphonylurea: A 52-week open-label, randomized phase III trial

215 JC231

1397/12/04

DEXAMETHASONE STRESS TEST: A PILOT CLINICAL STUDY FOR IDENTIFICATION OF INDIVIDUALS HIGHLY PRONE TO DEVELOP TYPE 2 DIABETES

216 JC232

1397/12/04

Gestational Weight Gain in Women With Polycystic Ovary Syndrome: A Controlled Study

217 JC234

1397/12/11

One-Hour and Twe-Hour Postload Glucose Level on Oral Glucose Tolerance Test and the Risk of Incident Metabolic Syndrome

218 JC235

1397/12/18

The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome

219 JC236

1397/12/18

Clinical Practice Update on Testosterone Therapy for Male Hypogonadism: Contrasting Perspectives to Optimize Care

220 JC237

1398/01/17

Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception

221 JC238

1398/01/17

The Natural History of Adrenal Insufficiency in X-Linked Adrenoleukodystrophy: An International Collaboration

222 JC239

1398/01/24

Accuracy of Anti-Müllerian Hormone and total Follicles Count to Diagnose Polycystic Ovary Syndrome in Reproductive Women

223 JC240

1398/01/24

Systemic Thyroid Hormone Status During Levothyroxine Therapy in Hypothyroidism: A Systematic Review and Meta-Analysis

224 JC241

1398/01/31

Body-Weight Fluctuation and Incident Diabetes Mellitus, Cardiovascular Disease, and Mortality: A 16-Year Prospective Cohort Study

225 JC242

1398/01/31

Lipid-Lowering Agents in Older Individuals: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

226 JC233

1397/12/11

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Hypothalamic-Pituitary-Adrenal Axis in Healthy Volunteers

227 JC228

1397/11/13

Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer

228 JC227

1397/11/13

Effects of SGLT2 Inhibitors on Circulating Stem and Progenitor Cells in Patients With Type 2 Diabetes

229 JC226

1397/11/06

Reducing the Number of Unnecessary Thyroid Biopsies While Improving Diagnostic Accuracy

230 JC215

1397/09/24

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

231 JC212

1397/09/17

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes

232 JC213

1397/09/17

The Association of Maternal Thyroid Autoimmunity During Pregnancy With Child IQ

233 JC214

1397/09/24

Lactating Mothers and Infants Residing in an Area with an Effective Salt Iodization Program Have No Need for Iodine Supplements: Results from a Double-Blind, Placebo-Controlled, Randomized Controlled Trial

234 JC216

1397/09/24

PCSK9 — A Journey to Cardiovascular Outcomes

235 JC217

1397/10/01

Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus

236 JC218

1397/10/08

Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia

237 JC219

1397/10/15

Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care

238 JC225

1397/11/06

Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease

239 JC224

1397/10/29

Radioactive Iodine–Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival

240 JC223

1397/10/29

Effects of Altering Levothyroxine Dose on Energy Expenditure and Body Composition in Subjects Treated With LT4

241 JC222

1397/10/22

High-Dose, Diazoxide-Mediated Insulin Suppression Boosts Weight Loss Induced by Lifestyle Intervention

242 JC221

1397/10/22

Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease

243 JC220

1397/10/15

Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality

244 JC255

1400/02/30

Prevalence of Iodine-Induced Hyperthyroidism After Administration of Iodinated Contrast During Radiographic Procedures: A Systematic Review and Meta-Analysis of the Literature

245 JC256

1400/02/30

Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma

246 JC257

1400/03/06

Urinary polycyclic aromatic hydrocarbons and sex hormones in children and adolescents: Evidence from NHANES

247 JC258

1400/03/06

Long-term efficacy and safety of percutaneous ethanol injection (PEI) in cystic thyroid nodules: A systematic review and meta-analysis

248 JC259

1400/03/13

Which parameters predict the beneficial effect of GnRHa treatment on height in girls with central precocious puberty?

249 JC260

1400/03/20

Osteoporosis, Fractures, and Bone Mineral Density Screening in Veterans With Kidney Stone Disease

250 JC261

1400/03/20

A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis

251 JC262

1400/03/27

Late Recovery of Parathyroid Function after Total Thyroidectomy in Children and Adults: Is There a Difference?

252 jc263

1400/03/27

Statins Decrease the Risk of Orbitopathy in Newly Diagnosed Patients with Graves Disease

253 JC264

1400/04/03

Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants

254 JC254

1400/02/16

High Diagnostic Accuracy of Subcutaneous Triptorelin test Compared with GnRH test for Diagnosing Central Precocious Puberty in Girls

255 JC253

1400/02/16

Therapeutic Equivalence of a New Preparation of Liquid Levothyroxine with Tablets in Patients with Overt Primary Hypothyroidism

256 JC265

1400/04/03

Clinical Outcomes After Discontinuation of Thyroid Hormone Replacement - A Systematic Review and Meta-Analysis

257 JC243

1398/02/07

Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort

258 JC244

1398/02/07

Primary Hyperparathyroidism in Pregnancy: Maternofetal Outcomes at a Quaternary Referral Obstetric Hospital, 2000 Through 2015

259 JC245

1400/01/19

Once-Weekly Semaglutide in Adults with Overweight or Obesity

260 JC246

1400/01/19

Cystic Adrenal Lesions: Focus on Pediatric Population (A Review)

261 JC247

1400/01/26

Endocrine Disruptors and Polycystic Ovary Syndrome: Phthalates

262 JC248

1400/01/26

Association of Thyroid Hormone Therapy with Mortality in Subclinical Hypothyroidism: A Systematic Review and Meta-analysis

263 JC250

1400/02/02

Subclinical Hypothyroidism

264 JC251

1400/02/09

Rapid Changes in Serum Testosterone in Men With Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin

265 JC252

1400/02/09

Insulin resistance and bone health in adolescents

266 JC249

1400/02/02

Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop Diuretics in Patients with Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial